Exelixis, Inc. (EXEL)
45.37
-0.87
(-1.88%)
USD |
NASDAQ |
Dec 29, 16:00
45.24
-0.13
(-0.29%)
After-Hours: 20:00
Exelixis Total Liabilities (Quarterly): 662.85M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Vanda Pharmaceuticals, Inc. | 135.14M |
| ADMA Biologics, Inc. | 137.50M |
| Aldeyra Therapeutics, Inc. | 28.56M |
| Neurocrine Biosciences, Inc. | 1.262B |
| Axsome Therapeutics, Inc. | 595.52M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 2.824B |
| Shareholders Equity (Quarterly) | 2.161B |
| Debt to Equity Ratio | 0.0817 |
| Current Ratio | 3.752 |
| Net Debt Paydown Yield | 0.04% |